Tytuł artykułu
Treść / Zawartość
Pełne teksty:
Identyfikatory
Warianty tytułu
Fluoroquinolone antibiotics and their structural modifications
Języki publikacji
Abstrakty
The quinolones are synthetic antibiotics derived from nalidixic acid. Chemical modification of basic structure (nalidixic acid) has led to the development of a group of various compounds currently used in medicine. This article discusses the generation of quinolones, mode of their action, and relationship between activity and structure of these antibiotics. The most common quinolones, lomefloxacin and sparfloxacin were discussed in details, also the therapeutic potential of newer agents was reviewed. Recently, understanding of how molecular modifications among quinolone core structure can affect antimicrobial and anticancer activities has progressed rapidly. In this paper we discussed few examples of fluoroquinolone structural modifications. It was proved that many organic and inorganic compounds derived from fluoroquinolones overcame bacterial drug-resistance. Furthermore, chemical modification improved fluoroquinolone’s anticancer activities.
Wydawca
Czasopismo
Rocznik
Tom
Strony
543--561
Opis fizyczny
Bibliogr. 70 poz., schem.
Twórcy
autor
- Wydział Chemii, Uniwersytet Wrocławski, ul. F. Joliot-Curie 14, 50-383 Wrocław
autor
- Wydział Chemii, Uniwersytet Wrocławski, ul. F. Joliot-Curie 14, 50-383 Wrocław
autor
- Wydział Chemii, Uniwersytet Wrocławski, ul. F. Joliot-Curie 14, 50-383 Wrocław
autor
- Wydział Chemii, Uniwersytet Wrocławski, ul. F. Joliot-Curie 14, 50-383 Wrocław
Bibliografia
- [1] K. Drlica, H. Hiasa, R. Kerns, M. Malik, A. Musta, Curr. Top. Med. Chem., 2009, 9, 981.
- [2] P. Chander, A. Jain, S. Jain, Acta Pol. Pharm. Res., 2009, 66, 587.
- [3] L.R. Peterson, Clin. Inf. Diseases, 2001, 33, 180.
- [4] G.S. Tillotson, J. Med. Microbiol., 1996, 44, 320.
- [5] A. George, Clin. Inf. Diseases, 2005, 4, 120.
- [6] Y. Xia, Z.Y. Yang, S.L. Morris-Natschke, K.H. Lee, Curr. Med. Chem., 1999, 6, 179.
- [7] A. Dalhoff, I. Shalit, Lancet Infect. Dis., 2003, 3, 359.
- [8] K. Kaur, M. Jain, R.P. Reddy, R. Jain, Eur. J. Med. Chem., 2010, 45, 3245.
- [9] K. Eleni, G. Psomas, Y. Sanakis, N. Katsaros, J. Inorg. Biochem., 2007, 101, 525.
- [10] P.C. Appelbaum, P.A. Hunter, Int. J. Antimicrob. Agents, 2000, 16, 5.
- [11] A. Lavie-Cambot, M. Cantuel, Y. Leydet, G. Jonusauskas, D. M. Bassani, N.D. McClenaghan, Coord. Chem. Rev., 2008, 252, 2572.
- [12] D.T.W. Chu, P.B. Fernandes, Adv. Drug Res., 1991, 21, 39.
- [13] Y. Zhao, Y. Chen, J. Sheu, I. Chen, T. Wang, C. Tzenga, Bioorg. Med. Chem., 2005, 13, 3921.
- [14] G.L. Patrick, An Introduction to Medicinal Chemistry, Oxford University Press, New York 2003.
- [15] M.V. De Almeida, M.F. Saraiva, M.V.N. De Souza, C.F. Da Costa, F.R.C. Vincente, M.C.S. Lourenco, Bioorg. Med. Chem. Lett., 2007, 17, 5661.
- [16] G. Anquetin, J. Greiner, N. Mahmoud, Eur. J. Med. Chem., 2006, 41, 1478.
- [17] E.M. Scholar, Am. J. Pharm. Educ., 2003, 66, 164.
- [18] F. Van Bambeke, J.-M. Michot , J. Van Eldere, P. M. Tulkens, Clin. Microbiol. Infect., 2005, 11, 256.
- [19] C.M. Oliphant, Am. Fam. Phys., 2002, 65, 455.
- [20] D.E. King, R. Malone, S.H. Lilley, Am. Fam. Phys., 2000, 61, 2741.
- [21] G.G. Zhanel, A. Walkty, L. Vercaigne, J.A. Karlowsky, J. Embil, A.S. Gin, D.J. Hoban, Can. J. Infect. Dis., 1999, 10, 207.
- [22] V. Uivarosi, Molecules, 2013, 18, 11153.
- [23] J. Cross, Semin, Pediatr. Infect. Dis., 2001, 12, 211.
- [24] J. Blondeau, Surv. Ophthalmol., 2004, 49, 73.
- [25] K. Drlica, Curr. Opin. Microbiol., 1995, 2, 504.
- [26] J. Katie, R. Aldred, J. Kerns, N. Osherof, Biochemistry, 2014, 53, 1565.
- [27] L.A. Mitscher, Chem. Rev., 2012, 105, 559.
- [28] K. Drlica, H. Hiasa, R. Kerns, M. Malik, A. Mustaev, X. Zhao, Curr. Top. Med. Chem., 2009, 9, 981.
- [29] V.E. Anderson, N. Osherof, Curr. Pharm. Des., 2009, 7, 337.
- [30] J.J. Champoux, Annu. Rev. Biochem., 2001, 70, 369.
- [31] Y. Pommier, E. Leo, H. Zhang, C. Marchand, Chem. Biol., 2010, 17, 421.
- [32] A.C. Gentry, N. Osheroff, Encyclopedia of Biological Chemistry, Elsevier Inc., Amsterdam 2013.
- [33] K. Chauhan, P. Singh, V. Kumar, P.K. Shukla, M. Imran, M.S. Chauhan, Eur. J. Med. Chem., 2014, 78, 442.
- [34] C. Marzano, V. Gandin, M. Pellei, D. Colavito, G. Papini, G. Gioia Lobbia, E. Del Giudice, M. Porchia, F. Tisato, C. Santini, J. Med. Chem. 2008, 51, 798.
- [35] M. Takemura, Farmaco, 2001, 56, 37.
- [36] O.K. Kim, K. Ohemeng, J.F. Barrett, Opin. Investig. Drugs, 2004, 10, 199.
- [37] K. Kawakami, H. Takahashi, H. Ohki, K. Kimura, S. Miyauchi, R. Miyauchi, M. Takemura, Chem. Pharm. Bull., 2010, 48, 1667.
- [38] N. Hayashi, K. Hashimoto, A. Yazaki, Antimicrob. Agents Chem., 2001, 4, 556.
- [39] J.C. Jung, Y.J. Jung, O.S. Park, J. Heterocyclic. Chem., 2001, 38, 61.
- [40] G.S. Tillotson, GS. J. Med. Microbiol., 1996, 44, 320.
- [41] F. Van Bambeke, J.-M. Michot, J. Van Eldere, P.M. Tulkens, Clin. Microbiol. Infect., 2005, 11, 256.
- [42] E. Pestova, J.J. Millichap, G.A. Noskin, L.R. Peterson, J. Antimicrob. Chemother., 2000, 45, 583.
- [43] R. Beyer, E. Pestova, J.J, Millichap, G.A. Noskin, L.R. Peterson, Antimicrob. Agents Chemother., 2000, 44, 798.
- [44] T.A. Davies, L.M. Kelly, G.A. Pankuch, K.L. Credito, M.R. Jacobs, Antimicrob. Agents. Chemother., 2000, 44, 304.
- [45] A.N. Wadworth, K.L. Goa, Drugs., 1991, 42, 1018.
- [46] R.C. Owens Jr, P.G. Ambrose, Med. Clin. N. Am., 2000, 84, 1447.
- [47] A. Mohamed, A. Ragh, A. Mohamed, A. Eldesouki, S. Mohamed, Spectrochim. Acta A, 2015, 138, 585.
- [48] J.J. Schentag, J. Clin. Ther., 2000, 22, 372.
- [49] J. Gong, X. Liu, B. Shang, S. Chen, Y. Zhen, Oncol. Rep., 2010, 23, 1747.
- [50] World Health Organization, Antibiotic resistance: Multi-country public awareness survey, 2015 (ISBN 978 92 4 150981 7).
- [51] G. Alvan, C. Edlund, A. Heddini, Drug Resist., 2011, 14, 70.
- [52] L.S. Redgrave, S.B. Sutton, M.A. Webber, L.J.V. Piddock, Trends Microb., 2014, 22, 8.
- [53] D.C. Hooper, Drugs, 1999, 58, 6.
- [54] D.C. Hooper, Clin. Infect. Dis., 2001, 32, 9.
- [55] B. Fournier, X., Zhao, T. Lu, K. Drlica, D.C. Hooper, Antimicrob. Agents Chemother., 2000, 44, 2160.
- [56] L.B. Price, A. Vogler, T. Pearson, J.D. Busch, J.M. Schupp, P. Keim, Antimicrob. Agents Chemother., 2003, 47, 2362.
- [57] S.K. Morgan-Linnell, L. Becnel Boyd, D. Steffen, L. Zechiedrich, Antimicrob. Agents Chemother., 2014, 53, 235.
- [58] K. Drlica, X. Zhao, Microbiol. Mol. Biol. Rev., 2013, 61, 377.
- [59] Li, Z. Deguchi, T. Yasuda, M. Kawamura, T. Kanematsu, E. Nishino, Y. Ishihara, S. Kawada, Antimicrob. Agents Chemother., 1998, 42, 3293.
- [60] A. Robicsek, G.A. Jacoby, D.C. Hooper, Lancet Infect. Dis., 2006, 6, 629.
- [61] J. Strahilevitz, G.A. Jacoby, D.C. Hooper, Clin. Microbiol. Rev., 2009, 22, 664.
- [62] J.H. Tran, G.A. Jacoby, Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 5638.
- [63] X. Xiong, E.H. Bromley, P. Oelschlaeger, D.N. Woolfson, J. Spencer, Nucleic Acids Res., 2011, 39, 3917.
- [64] A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M.J. Thun, CA-Cancer J. Clin., 2006, 56, 106.
- [65] B.K. Edwards, M.L. Brown, P.A. Wingo, H.L. Howe, E. Ward, L.A.G. Ries, D. Schrag, P.M. Jamison, A. Jemal, X. Cheng Wu, C. Friedman, L. Harlan, J. Warren, R.N. Anderson, L.W. Pickle, J. Natl. Cancer Inst., 2005, 97, 1407.
- [66] M.J. Renan, Mol. Carcinog., 1993, 7, 139.
- [67] D. Hanahan, R.A. Weinberg, Cell, 2000, 100, 57.
- [68] A.A. Rosenkranz, D.A. Jans, A.S. Sobolev, Immunol. Cell Biol., 2000, 78, 452
- [69] P. Dozzo, M.S. Koo, S. Berger, T.M. Forte, S.B. Kahl, J. Med. Chem., 2005, 48, 357.
- [70] Y. Berger, L. Ingrassia, R. Neier, L. Juillerat-Jeanneret, Bioorg. Med. Chem., 2003, 11, 1343.
Uwagi
Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2018).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-e2643253-8a3f-4886-840a-087079977b63